Normal mesenteric lymph ameliorates lipopolysaccharide challenge-induced spleen injury
Zhang, Li-min; Song, Wen; Cui, Hao; Xing, Li-qiang; Du, Hui-bo; Cui, Ying; Chen, Wei-hong; Zhao, Zi-gang; Niu, Chun-yu.
Acta cir. bras.;
30(9): 604-610, Sep. 2015. ilus
Artigo
em Inglês
| VETINDEX
| ID: vti-334066
Resumo
This study was conducted to investigate the effect of normal mesenteric lymph (NML) from mice on the spleen injury induced by lipopolysaccharide (LPS) challenge. Mice in the LPS and LPS+NML groups received an intraperitoneal injection of LPS (35 mg/kg) and kept for 6 h.. The mice in the LPS+NML group received NML treatment at 1 h after LPS injection. Afterward, the splenic morphology, the levels of lipopolysaccharide-binding protein (LBP), cluster of differentiation 14 (CD14), phosphorylation mitogen-activated protein kinases (MAPKs), and inflammatory mediators in splenic tissue were investigated.RESULTS:LPS injection induced spleen injury, increased the levels of LBP, CD14, tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6), and interferon γ (IFN-γ), and decreased the IL-4 content in the spleen. By contrast, NML treatment reversed these changes. Meanwhile, the LPS challenge decreased the phosphorylation levels of p38 MAPK, extracellular regulated protein kinases 1/2, and c-Jun N-terminal kinase (JNK). Moreover, the phosphorylation levels of p38 MAPK and JNK were further decreased by the NML administration. rRdThe normal mesenteric lymph treatment alleviated lipopolysaccharide induced spleen injury by attenuating LPS sensitization and production of TNF-α, IL-6, and IFN-γ.(AU)
Biblioteca responsável:
BR1.1
Localização: BR68.1
Texto completo